We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Syngenta Releases Innovotech from Right of First Refusal Obligation

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Syngenta Releases Innovotech from Right of First Refusal Obligation"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

"Agress® continues to show excellent results in recently completed field trials that expand its potential uses to high-value added crops such as fruits, vegetables and pulses," said Ken Boutilier, President and CEO of Innovotech. "While we are disappointed with this decision, the fact remains that Agress® has consistently shown that it is highly effective as a treatment for controlling seed-borne pathogens and as a plant spray. As such, we look forward to working with other industry participants who have expressed interest, as we continue to seek regulatory approval from the US Environmental Protection Agency."

Agress® addresses some major problems in agricultural crop protection related to the use of the important antibiotic Streptomycin for the treatment of crop diseases. Firstly, Streptomycin is used in human health and its use in agriculture has been banned in many countries, including Canada. Furthermore, in many regions where Streptomycin is used to manage crop diseases, microbial resistance to the antibiotic is becoming increasingly prevalent, making it an ineffective disease management option in those regions. Agress® has shown to be at least as effective as Streptomycin in preventing a number of bacterial diseases, without the environmental consequences.